Yahoo Finance Amazon's Grocery Push Takes 'Step Forward' With New Subscription Option
A new subscription option for Prime members marks an "important step" for Amazon's grocery strategy, according to one analyst.
A new subscription option for Prime members marks an "important step" for Amazon's grocery strategy, according to one analyst.
WEST ORANGE, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a leading global manufacturer of products that power, protect and connect electronic circuits, today announced its investor conference schedule for May 2024: Oppenheimer 19th Annual Industrial Growth Conference (Virtual)Farouq Tuweiq, CFOLynn Hutkin, VP Financial Reporting & Investor RelationsTuesday, May 7, 2024Conducting meetings throughout the day with a presentation at 1:30 pm ET Cowen 52nd Annual Te
ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2024, Donald Melnikoff joined electroCore as the Company’s SVP, Engineering, Regulatory, and Compliance; the Compensation Committee of electroCore’s Board of Directors granted 10,000 restricted stock units (“RSUs”) to Mr. Melnikoff in connection with the commencement of his employment. The RSUs were gran
LOS ANGELES, May 03, 2024 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of common stock, payable on May 31, 2024 to stockholders of record as of the close of business on May 17, 2024. Under our current dividend policy, the Company will target a cash dividend to our stockholders in the amount of $0.20 per share per annum, payable in equal $0.05 per share quarterly installments
New York, May 03, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) (“KRNL” or the “Company”), a special purpose acquisition company, announced today that it has elected to extend the period of time it has to consummate its initial business combination by one month from May 5, 2024 to June 5, 2024 (the “Extension”). The Extension is the fourth of six-monthly extensions permitted under the Company’s governing documents. Cautionary Statement Regarding Forward-Lookin
FOSTER CITY, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that it has granted as of May 1, 2024 an equity inducement award to Melita Sun Jung, the Company’s new Chief Business Officer, under the terms of the 2022 Employment Inducement Award Plan, as ame
DALLAS, May 03, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system (CNS), today announced that, on May 1, 2024, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, options to purchase 528,000 shares of the Company's common stock in connection with
Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from exercise of three-year warrants issued in offeringAUSTIN, Texas, May 03, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced the closing of its pr
Surprisingly upbeat Apple earnings were boosting spirits in the wait for the monthly jobs report.
Amgen stock neared its record high Friday after the company said it's "very encouraged" with midstage test results for its obesity treatment.
Tandem Diabetes stock rocketed Friday after the insulin pump-maker topped first quarter expectations. But DaVita stock reversed lower.
U.S. Treasury yields tumbled to multi-week lows on Friday after data showed the world's largest economy created fewer jobs than expected last month, reinforcing expectations that the Federal Reserve will start cutting interest rates later this year. Bowman also said she remains willing to raise the fed funds rate at a future meeting if data showed inflation has stalled or reversed.
Patterson-UTI Energy, Inc. (NASDAQ:PTEN) Q1 2024 Earnings Call Transcript May 2, 2024 Patterson-UTI Energy, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to the Patterson UTI First Quarter 2024 conference call. [Operator Instructions]. As a […]
BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024, Anika granted non-statutory stock options (“Options”) covering an aggregate of 3,800 shares of common stock at a per share exercise price of $26.49, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive
TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- (TSX: SBN; SBN.PR.A) S Split Corp. has declared monthly distributions, payable on May 31, 2024 to shareholders of record on May 15, 2024. Due to the decline in the net asset value (“NAV”) per unit below $16.50, the Company has suspended distributions on its Class A Shares in accordance with the Articles of Incorporation. The NAV per Unit on April 30, 2024 was $12.03. Share ClassTicker Amount Per ShareClass A SharesSBN$0.00000Preferred SharesSBN.PR.A$0.04
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 31,750 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 47,625 shares of Vor Bio’s common stock to six newly hired employees. The foregoing stock op
BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on April 30, 2024, the company granted equity awards to ten new employees, pursuant to the company’s 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(
FORT WORTH, Texas, May 03, 2024--Omnicell to Present at the BofA Securities 2024 Health Care Conference
THOUSAND OAKS, Calif., May 03, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 4,150 restricted stock units of Atara’s common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara’s Board of Directors and granted under the Atara Biot
HAWTHORNE, Calif., May 03, 2024--OSI Systems, Inc. (NASDAQ: OSIS), today announced that it will be presenting at the Oppenheimer 19th Annual Industrial Growth Conference on Monday, May 6, 2024 at 12:45 PM ET.
NAARDEN, the Netherlands and MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s
